2nd Quarter - Report

PFIZER INC. for PFIZER INC.

Firm
Client
Income
—
Expenses
$1,620,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Deferral Excess Returns/Base Erosion Comprehensive Tax Reform Transition Rules for Comprehensive ReformTerritorial Systems Patent/Innovation Box Minimum Tax Taxation or Intangible Income Budget Base Erosion and Profit Shifting (BEPS)

LobbyistCovered position, as disclosed
PAULA BURG —
KEN W COLE —
JOHN PAUL HALLIWELL —
CAROLINE MOODY SCHELLHAS —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Commerce, Dept of (DOC); Natl Security Council (NSC); Treasury, Dept of; SENATE; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

Patent Settlements Patent Troll Legislation CMS Rule Preventing Abuse of Cough Treatment Act

LobbyistCovered position, as disclosed
PAULA BURG —
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); Food & Drug Administration (FDA); Executive Office of the President (EOP); Treasury, Dept of; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Patent & Trademark Office (PTO)

Health Issues HCR

Health Care Reform FDA Funding Prescription Drug User Fee Act (PDUFA) Implementation HHS AppropriationsInterior Appropriations

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
JENNIFER SWENSON WALTON —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Natl Security Council (NSC); Patent & Trademark Office (PTO); Executive Office of the President (EOP); State, Dept of (DOS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Treasury, Dept of

Medicare/Medicaid MMM

Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference SGR "Fix" Negotiations

LobbyistCovered position, as disclosed
PAULA BURG —
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Food & Drug Administration (FDA); Executive Office of the President (EOP); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Treasury, Dept of; Natl Security Council (NSC)

Alcohol and Drug Abuse ALC

Prescription Drug Abuse

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —

Contacted: Treasury, Dept of; Patent & Trademark Office (PTO); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Food & Drug Administration (FDA); State, Dept of (DOS)

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP)Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues Korea IP/Trade Issues China IP Saudia Arabia IP Turkey Pricing/IP

Contacted: Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Executive Office of the President (EOP); Commerce, Dept of (DOC); Treasury, Dept of; Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Consumer Issues/Safety/Products CSP

Certified Importer Program Supply Chain Issues Designer Anabolic Steroid Act

LobbyistCovered position, as disclosed
PAULA BURG —
ANGELA WALKER RIEMER —

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Treasury, Dept of; HOUSE OF REPRESENTATIVES; SENATE; Natl Security Council (NSC); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.